NYSE:GMREGlobal Medical REIT Stock Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Global Medical REIT Inc Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add $13.24 -0.02 (-0.15 %) (As of 08/14/2020 04:00 PM ET) Add Compare Share Today's Range$13.10Now: $13.24▼$13.3950-Day Range$10.46MA: $11.68▼$13.5152-Week Range$6.98Now: $13.24▼$15.95Volume144,654 shsAverage Volume413,695 shsMarket Capitalization$612.38 millionP/E Ratio165.52Dividend Yield6.04%Beta0.74 ProfileAnalyst RatingsChartCompetitorsDividendEarningsInsider TradesInstitutional OwnershipHeadlinesOptions ChainShort InterestSocial Media Global Medical REIT, Inc. engages in the acquisition of purpose-built healthcare facilities and leasing of those properties to strong healthcare systems and physician groups. The company was founded on March 18, 2011 and is headquartered in Bethesda, MD.Read More Beat the Market (BTM) Rank™ 2.5 Analyst's Opinion Consensus RatingGlobal Medical REIT has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 6 buy ratings, no hold ratings, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $14.75, Global Medical REIT has a potential upside of 11.4% from its current price of $13.24.Amount of Analyst CoverageGlobal Medical REIT has only been the subject of 1 research reports in the past 90 days. Previous Next 2.5 Community Rank Outperform VotesGlobal Medical REIT has received 268 “outperform” votes. (Add your “outperform” vote.)Underperform VotesGlobal Medical REIT has received 259 “underperform” votes. (Add your “underperform” vote.)Community SentimentGlobal Medical REIT has received 50.85% “outperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about Global Medical REIT and other stocks. Vote “Outperform” if you believe GMRE will outperform the S&P 500 over the long term. Vote “Underperform” if you believe GMRE will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 1.7 Dividend Strength Dividend LeadershipGlobal Medical REIT is a leading dividend payer. It pays a dividend yield of 6.04%, putting its dividend yield in the top 25% of dividend-paying stocks.Dividend GrowthGlobal Medical REIT has only been increasing its dividend for 1 years.Dividend CoverageThe dividend payout ratio of Global Medical REIT is 106.67%. Payout ratios above 75% are not desirable because they may not be sustainable.Dividend SustainabilityBased on EPS estimates, Global Medical REIT will have a dividend payout ratio of 83.33% in the coming year. This indicates that Global Medical REIT may not be able to sustain their current dividend. Previous Next 4.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Global Medical REIT insiders have bought more of their company's stock than they have sold. Specifically, they have bought $26,600.00 in company stock and sold $0.00 in company stock.Percentage Held by InsidersOnly 9.40% of the stock of Global Medical REIT is held by insiders.Percentage Held by Institutions58.46% of the stock of Global Medical REIT is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for Global Medical REIT are expected to grow by 15.66% in the coming year, from $0.83 to $0.96 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Global Medical REIT is 165.52, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 17.41.Price to Earnings Ratio vs. SectorThe P/E ratio of Global Medical REIT is 165.52, which means that it is trading at a more expensive P/E ratio than the Finance sector average P/E ratio of about 19.60.Price to Book Value per Share RatioGlobal Medical REIT has a P/B Ratio of 1.27. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Previous Next Analyst Opinion: 2.5Community Rank: 2.5Dividend Strength: 1.7Insider Behavior: 4.0Valuation: 0.6 5 -4 -3 -2 -1 -Overall Beat the Market Rank™2.26 out of 5 stars Industry, Sector and Symbol Stock Exchange NYSE Industry Real estate investment trusts Sub-IndustryN/A SectorFinance Current SymbolNYSE:GMRE Previous Symbol CUSIPN/A CIKN/A Webwww.globalmedicalreit.com Phone202-524-6851Debt Debt-to-Equity Ratio1.19 Current Ratio0.37 Quick Ratio0.37Price-To-Earnings Trailing P/E Ratio165.52 Forward P/E Ratio15.95 P/E GrowthN/A Sales & Book Value Annual Sales$70.73 million Price / Sales8.66 Cash Flow$0.80 per share Price / Cash Flow16.47 Book Value$10.45 per share Price / Book1.27Profitability EPS (Most Recent Fiscal Year)$0.75 Net Income$9.23 million Net Margins7.81% Return on Equity1.85% Return on Assets0.73%Miscellaneous EmployeesN/A Outstanding Shares46,252,000Market Cap$612.38 million Next Earnings Date11/4/2020 (Estimated) OptionableOptionable $13.24 -0.02 (-0.15 %) (As of 08/14/2020 04:00 PM ET) 30 days | 90 days | 365 days | Advanced Chart Receive GMRE News and Ratings via Email Sign-up to receive the latest news and ratings for GMRE and its competitors with MarketBeat's FREE daily newsletter. Global Medical REIT (NYSE:GMRE) Frequently Asked Questions How has Global Medical REIT's stock price been impacted by Coronavirus (COVID-19)? Global Medical REIT's stock was trading at $12.41 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, GMRE stock has increased by 6.7% and is now trading at $13.24. View which stocks have been most impacted by COVID-19. Do Wall Street analysts recommend investors buy shares of Global Medical REIT? 6 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Global Medical REIT in the last year. There are currently 6 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Global Medical REIT. When is Global Medical REIT's next earnings date? Global Medical REIT is scheduled to release its next quarterly earnings announcement on Wednesday, November 4th 2020. View our earnings forecast for Global Medical REIT. How were Global Medical REIT's earnings last quarter? Global Medical REIT Inc (NYSE:GMRE) posted its quarterly earnings results on Wednesday, May, 6th. The company reported $0.03 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.20 by $0.17. The company earned $21.65 million during the quarter, compared to the consensus estimate of $21.04 million. Global Medical REIT had a return on equity of 1.85% and a net margin of 7.81%. View Global Medical REIT's earnings history. How often does Global Medical REIT pay dividends? What is the dividend yield for Global Medical REIT? Global Medical REIT announced a quarterly dividend on Friday, June 12th. Investors of record on Thursday, June 25th will be paid a dividend of $0.20 per share on Thursday, July 9th. This represents a $0.80 annualized dividend and a dividend yield of 6.04%. The ex-dividend date of this dividend is Wednesday, June 24th. View Global Medical REIT's dividend history. What price target have analysts set for GMRE? 6 equities research analysts have issued 12-month price targets for Global Medical REIT's stock. Their forecasts range from $12.00 to $17.00. On average, they anticipate Global Medical REIT's share price to reach $14.75 in the next twelve months. This suggests a possible upside of 11.4% from the stock's current price. View analysts' price targets for Global Medical REIT. Has Global Medical REIT been receiving favorable news coverage? News headlines about GMRE stock have been trending somewhat positive this week, InfoTrie Sentiment Analysis reports. InfoTrie identifies positive and negative media coverage by monitoring more than six thousand news and blog sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Global Medical REIT earned a news impact score of 0.6 on InfoTrie's scale. They also assigned news stories about the company a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an effect on the stock's share price in the immediate future. View the latest news about Global Medical REIT. Are investors shorting Global Medical REIT? Global Medical REIT saw a increase in short interest in May. As of May 29th, there was short interest totaling 748,400 shares, an increase of 25.5% from the May 14th total of 596,500 shares. Based on an average trading volume of 507,000 shares, the short-interest ratio is currently 1.5 days. View Global Medical REIT's Short Interest. Who are some of Global Medical REIT's key competitors? Some companies that are related to Global Medical REIT include Weingarten Realty Investors (WRI), Taubman Centers (TCO), Outfront Media (OUT), Apple Hospitality REIT (APLE), National Storage Affiliates Trust (NSA), Great Portland Estates (GPEAF), Ryman Hospitality Properties (RHP), Safestore (SFSHF), CHIMERA INVT CO/SH NEW (CIM), Brandywine Realty Trust (BDN), Easterly Government Properties (DEA), Washington Real Estate Investment Trust (WRE), Uniti Group (UNIT), PennyMac Mortgage Investment Trust (PMT) and Caretrust REIT (CTRE). View all competitors. What other stocks do shareholders of Global Medical REIT own? Based on aggregate information from My MarketBeat watchlists, some companies that other Global Medical REIT investors own include Principal Financial Group (PFG), Insys Therapeutics (INSY), General Electric (GE), New Residential Investment (NRZ), Square (SQ), AGNC Investment (AGNC), Big Lots (BIG), Energy Transfer LP Unit (ET), AT&T (T) and Medical Properties Trust (MPW). Who are Global Medical REIT's key executives? Global Medical REIT's management team includes the following people: Jeffrey Mark Busch, Chairman, President & Chief Executive OfficerDanica Holley, Chief Operating OfficerRobert J. Kiernan, Chief Financial Officer & TreasurerAlfonzo Leon, Chief Investment OfficerAllen E. Webb, Senior VP-SEC Reporting & Technical Accounting When did Global Medical REIT IPO? (GMRE) raised $130 million in an IPO on Wednesday, June 29th 2016. The company issued 13,000,000 shares at a price of $10.00 per share. Wunderlich and Oppenheimer acted as the underwriters for the IPO and BB&T Capital Markets, Compass Point and D.A. Davidson were co-managers. What is Global Medical REIT's stock symbol? Global Medical REIT trades on the New York Stock Exchange (NYSE) under the ticker symbol "GMRE." Who are Global Medical REIT's major shareholders? Global Medical REIT's stock is owned by a variety of retail and institutional investors. Top institutional investors include Vanguard Group Inc. (9.04%), Bank of New York Mellon Corp (3.53%), Prudential Financial Inc. (2.57%), Kranot Hishtalmut Le Morim Ve Gananot Havera Menahelet LTD (2.25%), Pacific Ridge Capital Partners LLC (1.34%) and Psagot Investment House Ltd. (1.06%). Company insiders that own Global Medical REIT stock include Henry Cole, Ronald Marston, Roscoe M Moore Jr and Zh Usa, Llc. View institutional ownership trends for Global Medical REIT. Which major investors are selling Global Medical REIT stock? GMRE stock was sold by a variety of institutional investors in the last quarter, including Psagot Investment House Ltd., ICM Asset Management Inc. WA, UBS Group AG, Meitav Dash Investments Ltd., WINTON GROUP Ltd, Virtus ETF Advisers LLC, ClariVest Asset Management LLC, and Robertson Stephens Wealth Management LLC. View insider buying and selling activity for Global Medical REIT. Which major investors are buying Global Medical REIT stock? GMRE stock was acquired by a variety of institutional investors in the last quarter, including Bank of New York Mellon Corp, Pacific Ridge Capital Partners LLC, SG Americas Securities LLC, Kranot Hishtalmut Le Morim Ve Gananot Havera Menahelet LTD, Bullseye Asset Management LLC, Russell Investments Group Ltd., Anchor Capital Advisors LLC, and Stifel Financial Corp. Company insiders that have bought Global Medical REIT stock in the last two years include Henry Cole, Ronald Marston, and Zh Usa, Llc. View insider buying and selling activity for Global Medical REIT. How do I buy shares of Global Medical REIT? Shares of GMRE can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. What is Global Medical REIT's stock price today? One share of GMRE stock can currently be purchased for approximately $13.24. How big of a company is Global Medical REIT? Global Medical REIT has a market capitalization of $612.38 million and generates $70.73 million in revenue each year. The company earns $9.23 million in net income (profit) each year or $0.75 on an earnings per share basis. What is Global Medical REIT's official website? The official website for Global Medical REIT is www.globalmedicalreit.com. How can I contact Global Medical REIT? Global Medical REIT's mailing address is 2 Bethesda Metro Center Suite 440, BETHESDA MD, 20814. The company can be reached via phone at 202-524-6851. This page was last updated on 8/15/2020 by MarketBeat.com Staff 30 Days of MarketBeat All Access for $1.00 Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your Risk-Free Trial Subscription Here Questions? Get Started with MarketBeat — Read Your Daily NewsletterCheck Out My MarketBeatWatch Our Tutorial VideosAdd a Stock to Your WatchlistSet Up an Instant AlertView a Company's Profile PageView Our Financial CalendarsView Today's Analyst Ratings
